133 related articles for article (PubMed ID: 3157817)
1. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
Nakata K; Suda H; Yamauchi H; Iso T
Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].
Fujimura H; Hiramatsu Y; Tamura Y; Yanagihara M; Koda A; Nagai H; Uda K; Iso T; Yamauchi H
Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
4. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ferulic acid on allergic reaction].
Hu HJ; Hang BQ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
[TBL] [Abstract][Full Text] [Related]
6. [Effect of KC-404 on allergic reactions types I-IV].
Nishino K; Hara S; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
Omote M; Sakai K; Mizusawa H
Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
Yamauchi H; Hayashi M; Kasamatsu S; Suda H; Nakata K; Sasano M; Iso T
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):275-82. PubMed ID: 2408978
[TBL] [Abstract][Full Text] [Related]
10. [Action of piroxicam on allergic inflammation].
Abe N; Tanaka K; Kanaoka K; Egawa M; Watanabe I; Hirai S
Nihon Yakurigaku Zasshi; 1983 May; 81(5):431-40. PubMed ID: 6629214
[TBL] [Abstract][Full Text] [Related]
11. SA96: an immunopharmacological profile in vitro.
Yamamoto I; Ohmori H; Okimura T
Int J Tissue React; 1982; 4(1):1-8. PubMed ID: 7200957
[TBL] [Abstract][Full Text] [Related]
12. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats.
Hayashi M; Matsunaga K; Okahara A; Mita S
J Rheumatol; 1991 May; 18(5):691-5. PubMed ID: 1865415
[TBL] [Abstract][Full Text] [Related]
13. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
Takahashi K; Endoh K; Yamada N; Kadowaki S; Arai Y; Sugasawa K
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of dehydrocorydaline isolated from Corydalis Tuber against type I-IV allergic models.
Matsuda H; Tokuoka K; Wu J; Shiomoto H; Kubo M
Biol Pharm Bull; 1997 Apr; 20(4):431-4. PubMed ID: 9145224
[TBL] [Abstract][Full Text] [Related]
16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
Tomioka K; Yamada T; Mase T; Murase K
Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunomodulators on candidacidal activity of normal peritoneal cells in BALB/c mice.
Hayashi M; Abe C; Nozawa RT; Yokota T; Iso T; Shiokawa Y
Int J Immunopharmacol; 1986; 8(3):299-304. PubMed ID: 3733301
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of methanolic extract from corydalis tuber against types I-IV allergic models.
Matsuda H; Tokuoka K; Wu J; Tanaka T; Kubo M
Biol Pharm Bull; 1995 Jul; 18(7):963-7. PubMed ID: 7581251
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
